Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 1/7/2019

Budget: Negotiable

Opportunity: PA-18-286

http://grants.nih.gov/grants/guide/pa-files/PA-18-286.html

The purpose of this FOA is to encourage submission of Exploratory/Developmental Bioengineering Research Grants (EBRG) applications which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.

Leave a Reply